Outlook on the DNA Vaccines Global Market to 2026 - Featuring Astellas Pharma, AstraZeneca and Pfizer Among Others
August 31, 2021 05:23 ET
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "DNA Vaccines: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for DNA...
Key Patent Issued on Qantu's QT-0101 Adjuvant
February 25, 2019 05:00 ET
|
QANTU Therapeutics, Inc.
LEWISVILLE, Texas, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Qantu Therapeutics, Inc. announces the issuance of United States patent 10,195,257 titled “Vaccine Formulations Comprising Quillaja...
Breast Cancer Study With Hemispherx Biopharma's Ampligen(R) Commences
August 22, 2011 10:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Aug. 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that investigators from the Tumor Vaccine Group (TVG) at the University of Washington in Seattle, WA,...
Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute
June 21, 2011 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, June 21, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that it has entered into a Material Transfer and Research...